抑制性突触的GABA-依赖的微质消除是中神经元过敏的基础
Zhang-Peng Chen1,2,3,4,5, Xiansen Zhao1, Suji Wang1
1State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.
Nature neuroscience
|May 27, 2025
概括
抑制性神经元激活微质来消除抑制性突触,恶化神经元过敏性在. 阻止这种微质通路可以减少小鼠的发作.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 病理生理学 病理生理学
背景情况:
- 神经元过度兴奋是神经系统疾病的标志.
- 神经元 - 质相互作用涉及但尚未完全理解.
- 微质细胞在突触修剪和大脑中的免疫反应中发挥着关键作用.
研究的目的:
- 阐明微质在驱动神经元过度兴奋中的作用.
- 为了研究中微质介导突触消除的机制.
- 为了确定的潜在治疗标.
主要方法:
- 使用的小鼠模型 (叶).
- 通过GABAergic信号传递来自过度活跃的神经元的微质激活进行了研究.
- 研究了GABA-B受体的作用和补充C3-C3aR途径在微细胞化中的作用.
- 在性脑组织中分析了细胞与细胞的相互作用.
主要成果:
- 过度活跃的抑制神经元通过GABAergic信号激活微质细胞.
- 激活的微质细胞选择性地抑制了细胞酶的突触,破坏了突触平衡.
- 阻断GABA-B受体或C3-C3aR通路可以防止突触损失并减少发作的严重程度.
- 抑制性神经元诱导微质的细胞状态和叶的突触损失.
结论:
- 抑制性突触的微介导消除是驱动中神经元过度兴奋的关键机制.
- 存在一个反循环,在这种循环中,抑制性神经元会激活微质来削减抑制性突触.
- 向微质激活和吞细胞路径为提供了一个潜在的治疗策略.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
685
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
685
Antiepileptic Drugs: Glutamate Antagonists
528
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
528
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
463
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
463
Antiepileptic Drugs: Potassium Channel Activators
291
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
291
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.7K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.7K
Epilepsy and Seizures: Overview
297
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
297


